Vaccination generates functional progenitor tumor-specific CD8 T cells and long-term tumor control.
Carlos R Detrés RománMichael W RudloffFrank RevettaNatalie R FavretKristen A MurrayJessica J RoetmanMegan M ErwinMary K WashingtonMary PhilipPublished in: bioRxiv : the preprint server for biology (2024)
For people at high-risk of cancer progression, vaccination administered when a responsive progenitor TST population is present may be the optimal immunotherapy to induce long-lasting progression-free survival.